Curaleaf Holdings, Inc.

CURLF OTC SEC CIK 1756770
Follow Curaleaf Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Revenue, last quarter $352.7M +10.9% vs same quarter last year
Net income −$32.7M +42.6% vs same quarter last year
EPS, diluted −$0.12 +52% vs same quarter last year
Operating cash flow $21.1M −55.8% vs same quarter last year
Revenue by quarter
$310.6M
$317.9M
$333.1M
$340.1M
$352.7M
Q2 25 Q3 25 Q4 25 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income6 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1B$1.5BFY20FY21FY22FY23FY24FY25
Show the numbers
YearRevenueNet income
FY25$1.3B−$231.1M
FY24$1.3B−$215.4M
FY23$1.3B−$281.2M
FY22$1.3B−$370.1M
FY21$1.2B−$205.9M
FY20--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−40%−20%0%20%40%60%FY20FY21FY22FY23FY24FY25
Show the numbers
YearGross marginOperating marginNet margin
FY2549.8%2%−18.2%
FY2448%1.9%−16.1%
FY2345.6%3.2%−20.9%
FY2249.1%5.1%−29%
FY2147.6%4.9%−17.2%
FY20---
Free cash flowOperating cash flow minus capital expenditure
−$300M−$200M−$100M$0$100MFY20FY21FY22FY23FY24FY25
Show the numbers
YearFree cash flow
FY25$74.3M
FY24$71.2M
FY23$9.8M
FY22−$88.2M
FY21−$230.2M
FY20-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • Curaleaf
  • Healthcare median
−100%−75%−50%−25%0%FY20FY21FY22FY23FY24FY25
Show the numbers
YearCuraleafHealthcare median
FY25−18.2%−30.6%
FY24−16.1%−47%
FY23−20.9%−58%
FY22−29%−80.4%
FY21−17.2%−71.9%
FY20-−62.2%